Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant. Read more about Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.
Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report. Read more about Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report.
Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report. Read more about Anthracyclines in a patient with acute leukemia and severe cardiomyopathy requiring mechanical support: A case report.
Evaluation of subcutaneous daratumumab injections in the ambulatory care setting. Read more about Evaluation of subcutaneous daratumumab injections in the ambulatory care setting.
The limitations of today's clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting. Read more about The limitations of today's clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting.
Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. Read more about Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma.
